Careers News Investors
Home

ACTICOAT TwoWeek Challenge

ACTICOAT ◊ Two-Week Challenge

Train your terrier in just two weeks? Maybe not…but you could find a route to help control infection.1-5

Invite your team to take the ACTICOAT Two-Week Challenge.

Contact your local representative to get started.

GMC1748 ACTICOAT 2-Week Challenge Toolkit Landing page p3 J2W v1.0.png

Why take the challenge?

Find a fast path to healing in just two weeks*5-8

Given the cost, burden and patient impact of infected wounds, can wound infection be mastered in just two weeks? It’s unlikely…but you could find a route to help control wound infection using ACTICOAT Dressings on suitable patients.4,9-14

  • Effective against over 150 pathogens**15-19
  • Suitable for use across a variety of hard-to-heal wounds
  • Shown to resolve the clinical signs of infection in 60% of chronic wound patients in two weeks***5
  • Helps to promote reduction in wound infection 5,15,17,2,3

 

ACTICOAT Dressings rapidly kill bacteria in as little as 30 minutes**20-23

How the challenge works

Use ACTICOAT Dressings on wounds displaying signs and symptoms of infection, and after two weeks:

If the wound has improved but signs of infection are still present: Continue use as needed with regular reviews.

If signs and symptoms of infection are no longer present: Discontinue use and step down to an appropriate dressing.

If the wound shows no improvement: Discontinue use and refer to an appropriate specialist if there’s no improvement.

GMC1748 ACTICOAT 2-Week Challenge Toolkit Landing page p5 T2 v1.0.png

How ACTICOAT Dressings work

Choosing the right patients

The ACTICOAT Two-Week Challenge could highlight a path to help take control of infection1-5 and help support antimicrobial stewardship, but identifying the right patients is crucial.
Following the principles of best practice, it has been shown that accurate decision-making, a fast response and effective treatment choices help improve patient outcomes.24 Use our infection management pathway to help identify suitable patients with wounds showing signs and symptoms of infection.

Download the infection management pathway

Additional resources

Disclaimers



*Compared to standard treatment.

**As demonstrated in vitro.

***n=75.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

 
Citations
  1. Strohal R, et al. J Hosp Infect. 2005; 60(3):226 - 230. 
  2. Chaloner D, et al. A comparative study of two silver containing dressings, ACTICOAT 7 and Avance, in the treatment of chronic venous ulcers. Poster presented at: WUWHS 2004; Paris. 
  3. Gravante G, et al. Annal of plastic surgery. 2009;63:201-205.
  4. Glik J, et al. Int Wound J. 2018;15(3):344 - 349.
  5. Gago M, et al. Wounds. 2008;20(10):273 - 278.
  6. Cuttle L, et al. Burns. 2007;33(6):701 - 707. 
  7. Smith+Nephew 2020. Internal Report. EO.AWM.PCS105.001.v2. 
  8. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.003.v2.
  9. Ayello EA, et al. Int Wound J. 2012;1–24.
  10. Driffield K, et al. The use of silver containing dressings to prevent biofilm formation by single and mixed bacterial flora. Poster Presentation in SWC. 2007. 
  11. Schultz G, et al. Wound Repair Regen. 2017;25:744–757. 
  12. Strand O, et al. Ann Burns Fire Disasters. 2010;23(4):182–185. 
  13. Tonkin C, et al. Primary Intention. 2005;13(4):163–168.
  14. Fong J, et al. Burns. 2005;31(5):562–567.
  15. Smith+Nephew 2008. Internal Report. DOF 0810016. 
  16. Smith+Nephew 2008. Internal Report. DOF 0810017.
  17. Smith+Nephew 2008. Internal Report. DOF 0810012. 
  18. Smith+Nephew 2008. Internal Report. DOF 0810013. 
  19. Smith+Nephew 1993. Internal Report. Report 93/001. 
  20. Wright JB, et al. Wounds. 1998;10(6):179 - 188. 
  21. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195 - 200. 
  22. Smith+Nephew 2008. Internal Report. DOF 0810018
  23. Wright JB, et al. Am J Infect Control. 1998;26(6):572 – 577.
  24. International Wound Infection Institute (IWII) Wound infection in clinical practice. Wounds International (2016).

Title

Text

Explore